211 related articles for article (PubMed ID: 30034506)
1. Efficacy of N-carbamoyl-L-glutamic acid for the treatment of inherited metabolic disorders.
Chapel-Crespo CC; Diaz GA; Oishi K
Expert Rev Endocrinol Metab; 2016; 11(6):467-473. PubMed ID: 30034506
[TBL] [Abstract][Full Text] [Related]
2. N-carbamylglutamate markedly enhances ureagenesis in N-acetylglutamate deficiency and propionic acidemia as measured by isotopic incorporation and blood biomarkers.
Tuchman M; Caldovic L; Daikhin Y; Horyn O; Nissim I; Nissim I; Korson M; Burton B; Yudkoff M
Pediatr Res; 2008 Aug; 64(2):213-7. PubMed ID: 18414145
[TBL] [Abstract][Full Text] [Related]
3. Carglumic acid for the treatment of N-acetylglutamate synthase deficiency and acute hyperammonemia.
Häberle J
Expert Rev Endocrinol Metab; 2012 May; 7(3):263-271. PubMed ID: 30780843
[TBL] [Abstract][Full Text] [Related]
4. A novel UPLC-MS/MS based method to determine the activity of N-acetylglutamate synthase in liver tissue.
Dercksen M; Duran M; IJlst L; Kulik W; Ruiter JP; van Cruchten A; Tuchman M; Wanders RJ
Mol Genet Metab; 2016 Dec; 119(4):307-310. PubMed ID: 27771289
[TBL] [Abstract][Full Text] [Related]
5. Precision medicine in rare disease: Mechanisms of disparate effects of N-carbamyl-l-glutamate on mutant CPS1 enzymes.
Shi D; Zhao G; Ah Mew N; Tuchman M
Mol Genet Metab; 2017 Mar; 120(3):198-206. PubMed ID: 28007335
[TBL] [Abstract][Full Text] [Related]
6. Normal Neurological Development During Infancy Despite Massive Hyperammonemia in Early Treated NAGS Deficiency.
Reigstad H; Woldseth B; Häberle J
JIMD Rep; 2017; 37():45-47. PubMed ID: 28275973
[TBL] [Abstract][Full Text] [Related]
7. Variant in the allosteric domain of CPS1 protein associated with effectiveness of N-carbamoyl glutamate therapy in neonatal onset CPS1 deficiency.
Gragnaniello V; Gueraldi D; Puma A; Commone A; Loro C; Cazzorla C; Häberle J; Burlina AB
J Pediatr Endocrinol Metab; 2023 Sep; 36(9):873-878. PubMed ID: 37427576
[TBL] [Abstract][Full Text] [Related]
8. Transporters involved in renal excretion of N-carbamoylglutamate, an orphan drug to treat inborn n-acetylglutamate synthase deficiency.
Schwob E; Hagos Y; Burckhardt G; Burckhardt BC
Am J Physiol Renal Physiol; 2014 Dec; 307(12):F1373-9. PubMed ID: 25354943
[TBL] [Abstract][Full Text] [Related]
9. Glucagon receptor signaling is not required for
Galsgaard KD; Pedersen J; Kjeldsen SAS; Winther-Sørensen M; Stojanovska E; Vilstrup H; Ørskov C; Wewer Albrechtsen NJ; Holst JJ
Am J Physiol Gastrointest Liver Physiol; 2020 May; 318(5):G912-G927. PubMed ID: 32174131
[TBL] [Abstract][Full Text] [Related]
10. Targeting CPS1 in the treatment of Carbamoyl phosphate synthetase 1 (CPS1) deficiency, a urea cycle disorder.
Diez-Fernandez C; Häberle J
Expert Opin Ther Targets; 2017 Apr; 21(4):391-399. PubMed ID: 28281899
[TBL] [Abstract][Full Text] [Related]
11. Partial N-acetyl glutamate synthase deficiency presenting as postpartum hyperammonemia: Diagnosis and subsequent pregnancy management.
Abou Haidar L; Pachnis P; Gotway GK; Ni M; DeBerardinis RJ; McNutt MC
JIMD Rep; 2023 Nov; 64(6):403-409. PubMed ID: 37927481
[TBL] [Abstract][Full Text] [Related]
12. Noncoding sequence variants define a novel regulatory element in the first intron of the N-acetylglutamate synthase gene.
Häberle J; Moore MB; Haskins N; Rüfenacht V; Rokicki D; Rubio-Gozalbo E; Tuchman M; Longo N; Yandell M; Andrews A; AhMew N; Caldovic L
Hum Mutat; 2021 Dec; 42(12):1624-1636. PubMed ID: 34510628
[TBL] [Abstract][Full Text] [Related]
13. Presentation and management of N-acetylglutamate synthase deficiency: a review of the literature.
Kenneson A; Singh RH
Orphanet J Rare Dis; 2020 Oct; 15(1):279. PubMed ID: 33036647
[TBL] [Abstract][Full Text] [Related]
14. Role of carglumic acid in the treatment of acute hyperammonemia due to N-acetylglutamate synthase deficiency.
Häberle J
Ther Clin Risk Manag; 2011; 7():327-32. PubMed ID: 21941437
[TBL] [Abstract][Full Text] [Related]
15. N-acetylglutamate synthase deficiency: an insight into the genetics, epidemiology, pathophysiology, and treatment.
Ah Mew N; Caldovic L
Appl Clin Genet; 2011; 4():127-35. PubMed ID: 23776373
[TBL] [Abstract][Full Text] [Related]
16. Gene delivery corrects N-acetylglutamate synthase deficiency and enables insights in the physiological impact of L-arginine activation of N-acetylglutamate synthase.
Sonaimuthu P; Senkevitch E; Haskins N; Uapinyoying P; McNutt M; Morizono H; Tuchman M; Caldovic L
Sci Rep; 2021 Feb; 11(1):3580. PubMed ID: 33574402
[TBL] [Abstract][Full Text] [Related]
17.
Yap S; Gougeard N; Hart AR; Barcelona B; Rubio V
JIMD Rep; 2019 Jul; 48(1):36-44. PubMed ID: 31392111
[No Abstract] [Full Text] [Related]
18. N-Acetylglutamate Synthase Deficiency Due to a Recurrent Sequence Variant in the N-acetylglutamate Synthase Enhancer Region.
Williams M; Burlina A; Rubert L; Polo G; Ruijter GJG; van den Born M; Rüfenacht V; Haskins N; van Zutven LJCM; Tuchman M; Saris JJ; Häberle J; Caldovic L
Sci Rep; 2018 Oct; 8(1):15436. PubMed ID: 30337552
[TBL] [Abstract][Full Text] [Related]
19. The efficacy of Carbamylglutamate impacts the nutritional management of patients with N-Acetylglutamate synthase deficiency.
Singh RH; Bourdages MH; Kurtz A; MacLoed E; Norman C; Ratko S; van Calcar SC; Kenneson A
Orphanet J Rare Dis; 2024 Apr; 19(1):168. PubMed ID: 38637895
[TBL] [Abstract][Full Text] [Related]
20. N-acetylglutamate synthase: structure, function and defects.
Caldovic L; Ah Mew N; Shi D; Morizono H; Yudkoff M; Tuchman M
Mol Genet Metab; 2010; 100 Suppl 1(Suppl 1):S13-9. PubMed ID: 20303810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
